INtestinal Dysbiosis and TRanslocation of Bacteria in Patients Undergoing Surgery
INTRA
Analysis of INtestinal Dysbiosis and TRanslocation of Bacteria in Patients Undergoing Abdominal Surgery
1 other identifier
observational
120
1 country
1
Brief Summary
The goal of this observational study is to contribute to a better understanding of the perioperative kinetics of intestinal microbial composition and association with surgical site infections. The main question this study aims to determine if:
- Patients undergoing surgery develop transient intestinal dysbiosis
- Such transient dysbiosis is associated with translocation to the systemic circulation and surgical site infection Patients undergoing elective abdominal surgery will be included prospectively. Informed consent will be obtained. From patients the following information and samples will be collected:
- Perioperative: Baseline health data, nutrition data, measurement body composition, glucose monitoring
- Intraoperatively:
- Mucosal swabs
- Blood from central venous catheter and portal vein
- Mesenteric lymph node
- Intestinal specimen
- Bile
- Subcutaneous biopsy
- Postoperatively:
- If a surgical site infection occurs samples from infected site
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 27, 2023
CompletedFirst Submitted
Initial submission to the registry
March 7, 2023
CompletedFirst Posted
Study publicly available on registry
March 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
April 29, 2026
April 1, 2026
3.8 years
March 7, 2023
April 28, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Changes of the intestinal microbiome between start and end of surgery
Score between PCA (principal components analysis) in the intestine between start (T1) and end (T2) of surgery. * Sampling: An intestinal specimen is dissected at start and end of elective pancreatic resections. * Processing: Samples are immediately processed for storage at -80° in glycerol. * Analysis: Quantification of total Biomass, DNA extraction, preparation of Bacterial DNA libraries, sequencing with Illumina system, downstream analysis, statistical analysis, principal components analysis (PCA) with all the samples is performed and the score is defined based on the distance between the two centers in PC1 and PC2 of T1 versus T2.
Day 0 (Day of Surgery)
Secondary Outcomes (4)
Bacterial taxonomy in the intestine
Day 0 (Day of Surgery)
Bacterial taxonomy MLN
Day 0 (Day of Surgery)
Bacterial taxonomy mucosal swabs
Day 0 (Day of Surgery)
Bacterial taxonomy in the blood
Day 0 (Day of Surgery)
Interventions
This is purely an observational study.
Eligibility Criteria
Patients undergoing elective abdominal surgery
You may qualify if:
- Patients undergoing laparoscopic colorectal resection with anastomosis or patients undergoing duodeno-pancreatectomy.
- Elective surgery
- Informed consent
- Age \> 18 years
You may not qualify if:
- Emergency surgery
- Other surgery 30 days prior to surgery
- BMI \<18 or \>50kg/m2
- Planed simultaneous second procedure with involvement of the intestinal tract
- Cholestasis with cholangitis, hepatic disease (defined as cirrhosis Child B or C) or renal disease (acute or chronic renal failure defined as eGFR≤ 30ml/min)
- Severe active enteritis or colitis, malabsorption, enteric infections
- Pancreatitis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beldi Guido
Bern, 3008, Switzerland
Biospecimen
Mucosal swabs, intestinal mucosa and content, serum, mesenteric lymph node, subcutaneous biopsy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Guido Beldi
Department of Visceral Surgery and Medicine, Bern University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 4 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 7, 2023
First Posted
March 20, 2023
Study Start
February 27, 2023
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
April 29, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share